These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29177427)

  • 1. Synaptic phosphorylated α-synuclein in dementia with Lewy bodies.
    Colom-Cadena M; Pegueroles J; Herrmann AG; Henstridge CM; Muñoz L; Querol-Vilaseca M; Martín-Paniello CS; Luque-Cabecerans J; Clarimon J; Belbin O; Núñez-Llaves R; Blesa R; Smith C; McKenzie CA; Frosch MP; Roe A; Fortea J; Andilla J; Loza-Alvarez P; Gelpi E; Hyman BT; Spires-Jones TL; Lleó A
    Brain; 2017 Dec; 140(12):3204-3214. PubMed ID: 29177427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.
    Walker DG; Lue LF; Adler CH; Shill HA; Caviness JN; Sabbagh MN; Akiyama H; Serrano GE; Sue LI; Beach TG;
    Exp Neurol; 2013 Feb; 240():190-204. PubMed ID: 23201181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.
    Vaikath NN; Erskine D; Morris CM; Majbour NK; Vekrellis K; Li JY; El-Agnaf OMA
    Neuropathol Appl Neurobiol; 2019 Oct; 45(6):597-608. PubMed ID: 30422353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.
    Kramer ML; Schulz-Schaeffer WJ
    J Neurosci; 2007 Feb; 27(6):1405-10. PubMed ID: 17287515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer's disease without conventional Lewy body pathology.
    Lewis KA; Su Y; Jou O; Ritchie C; Foong C; Hynan LS; White CL; Thomas PJ; Hatanpaa KJ
    Am J Pathol; 2010 Dec; 177(6):3037-50. PubMed ID: 21056999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
    Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.
    Rockenstein E; Nuber S; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Trejo-Morales M; Gerez J; Picotti P; Jensen PH; Campioni S; Riek R; Winkler J; Gage FH; Winner B; Masliah E
    Brain; 2014 May; 137(Pt 5):1496-513. PubMed ID: 24662516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.
    Martinez-Valbuena I; Amat-Villegas I; Valenti-Azcarate R; Carmona-Abellan MDM; Marcilla I; Tuñon MT; Luquin MR
    Acta Neuropathol; 2018 Jun; 135(6):877-886. PubMed ID: 29536165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.
    Walker DG; Lue LF; Tang TM; Adler CH; Caviness JN; Sabbagh MN; Serrano GE; Sue LI; Beach TG
    Neurobiol Aging; 2017 Jun; 54():175-186. PubMed ID: 28390825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.
    Muntané G; Dalfó E; Martinez A; Ferrer I
    Neuroscience; 2008 Apr; 152(4):913-23. PubMed ID: 18343584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic failure and α-synuclein.
    Calo L; Wegrzynowicz M; Santivañez-Perez J; Grazia Spillantini M
    Mov Disord; 2016 Feb; 31(2):169-77. PubMed ID: 26790375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convergence of pathology in dementia with Lewy bodies and Alzheimer's disease: a role for the novel interaction of alpha-synuclein and presenilin 1 in disease.
    Winslow AR; Moussaud S; Zhu L; Post KL; Dickson DW; Berezovska O; McLean PJ
    Brain; 2014 Jul; 137(Pt 7):1958-70. PubMed ID: 24860142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies.
    Beyer K; Domingo-Sàbat M; Santos C; Tolosa E; Ferrer I; Ariza A
    Brain; 2010 Dec; 133(Pt 12):3724-33. PubMed ID: 20959308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.
    Schulz-Schaeffer WJ
    Acta Neuropathol; 2010 Aug; 120(2):131-43. PubMed ID: 20563819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional Overlap of Pathologies in Lewy Body Disorders.
    Colom-Cadena M; Grau-Rivera O; Planellas L; Cerquera C; Morenas E; Helgueta S; Muñoz L; Kulisevsky J; Martí MJ; Tolosa E; Clarimon J; Lleó A; Gelpi E
    J Neuropathol Exp Neurol; 2017 Mar; 76(3):216-224. PubMed ID: 28395086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.
    Wetering JV; Geut H; Bol JJ; Galis Y; Timmermans E; Twisk JWR; Hepp DH; Morella ML; Pihlstrom L; Lemstra AW; Rozemuller AJM; Jonkman LE; van de Berg WDJ
    Acta Neuropathol Commun; 2024 May; 12(1):73. PubMed ID: 38715119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies.
    Hartlage-Rübsamen M; Bluhm A; Moceri S; Machner L; Köppen J; Schenk M; Hilbrich I; Holzer M; Weidenfeller M; Richter F; Coras R; Serrano GE; Beach TG; Schilling S; von Hörsten S; Xiang W; Schulze A; Roßner S
    Acta Neuropathol; 2021 Sep; 142(3):399-421. PubMed ID: 34309760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain.
    Roberts RF; Wade-Martins R; Alegre-Abarrategui J
    Brain; 2015 Jun; 138(Pt 6):1642-57. PubMed ID: 25732184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.
    Ortuño-Lizarán I; Beach TG; Serrano GE; Walker DG; Adler CH; Cuenca N
    Mov Disord; 2018 Aug; 33(8):1315-1324. PubMed ID: 29737566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies.
    van Steenoven I; Majbour NK; Vaikath NN; Berendse HW; van der Flier WM; van de Berg WDJ; Teunissen CE; Lemstra AW; El-Agnaf OMA
    Mov Disord; 2018 Nov; 33(11):1724-1733. PubMed ID: 30440090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.